SPX Controller

Literature Library

Clinical Data


Xoft offers patients and physicians a non-invasive alternative to surgery for non-melanoma skin cancer (NMSC) treatment. With the Xoft® Axxent® Electronic Brachytherapy (eBx®) System®, painless, scar-free treatment of NMSC is possible with skin eBx, a form of high dose rate, low energy radiation therapy. The Axxent SPX controller is a key component of the comprehensive skin eBx platform solution.

Specifically designed and wirelessly optimized for surface treatments, the Axxent SPX controller provides physicians with improved flexibility and scalability to treat NMSC lesions in a broader range of treatment environments. The controller offers enhanced patient positioning and comfort while simplifying the ability to target treatment with maximum precision. This highly mobile, easily transported unit features a bar code scanning mechanism to improve workflow efficiency and facilitate HIPAA compliance.

Combined with the comprehensive capabilities of the skin eBx platform solution, the Axxent SPX controller offers an attractive option to physicians and patients for improved flexibility, precision and personalization in the targeted treatment of NMSC.

  • Indications

    Skin eBx

    • Non-melanoma Skin Cancer (NMSC)
  • Features

    • Targeted non-melanoma skin cancer (NMSC) treatment results in excellent (>90%) cosmesis¹
    • Painless, non-invasive option for select patients
    • Ideal for challenging anatomic locations

    Xoft Axxent System is FDA cleared and CE marked in the EU for use anywhere in the body.

  • Related Products


©2018 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.  Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.